Allinky Biopharma
Records under this name other than the patents Allinky Biopharma holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 2 of 2 · Back to Allinky Biopharma
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,466,012 | Tetrahydroisoquinoline Compounds Lapsed on the fee record Ended Oct 11, 2026 · High confidence | Lapsed on the fee record | Ended Oct 11, 2026 | High confidence |
| US 9,908,896 | P38 and JNK MAPK inhibitors for the treatment and prophylaxis of degenerative diseases of the nervous system Lapsed on the fee record Ended Mar 6, 2022 · USPTO record | Lapsed on the fee record | Ended Mar 6, 2022 | USPTO record |